Just a small sample of recent wins...

ConforMIS is a privately held medical device company pioneering patient-specific orthopedic implants. In 2013, Aentib advised on ConforMIS’ series E financing round of $167.7M. Investors include: Top-tier Sovereign Wealth Funds, Government Investment Funds and Private Equity Funds in North America, Europe, Asia and the Middle East. 

Obalon Therapeutics Inc. is a California-based developer of a balloon-based weight loss device. Aentib advised Obalon on its $20 million, Series D funding round. Investors include both strategics and institutions. 

Argos Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases. Aentib Group advised Argos Therapeutics on its $60M financing.